Study register · detail
Review of the Use of Medicinal Cannabis Products in Palliative Care
Mixed
11 citations
SampleNarrative Review
Blindingunklar
DesignNarrative Review
Key finding
Limited evidence for efficacy in cancer pain and gastrointestinal symptoms; mixed results for insomnia and mood disorders; side effects documented.
Summary
Narrative review on medical cannabis products in palliative care for cancer; summarizing discussion on symptom management (pain, nausea, appetite, sleep), no systematic meta-analysis, primarily mechanistic and best-practice perspective.
SummaryNarrative review on the role of cannabis and cannabinoids in the palliative care setting in cancer patients. Limited evidence for pain and gastrointestinal symptoms (nausea, vomiting, loss of appetite); mixed results for sleep and mood disorders. Indication of neuropsychiatric and systemic side effects as well as interactions.
Quality profile
Sample size
—
Blinding
—
Effect size
Mixed
Citations / year
★★★★★
Authors
Share
Abstract
In this review, we discuss the potential role of cannabis and cannabinoids in the management of cancer-related symptoms. There is limited evidence demonstrating the effectiveness of cannabis-based products in treating cancer-related pain and gastrointestinal symptoms such as nausea, vomiting, and loss of appetite. Regarding the role of cannabis-based products in the treatment of insomnia and mood disorders, most studies looked at these symptoms as secondary outcomes with mixed results. Cannabis-based products have adverse effects, ranging from neuropsychiatric to systemic effects to potential drug interactions.
The impediment to action advances action.